STERIS plc Quarterly Deferred Income Tax Expense (Benefit) in USD from Q2 2018 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
STERIS plc quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q2 2018 to Q2 2024.
- STERIS plc Deferred Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was -$22.1M, a 4871% decline year-over-year.
- STERIS plc annual Deferred Income Tax Expense (Benefit) for 2023 was -$131M, a 29.3% increase from 2022.
- STERIS plc annual Deferred Income Tax Expense (Benefit) for 2022 was -$186M, a 74.4% decline from 2021.
- STERIS plc annual Deferred Income Tax Expense (Benefit) for 2021 was -$107M, a 2615% decline from 2020.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)